1. Home
  2. Labeler Index
  3. Heel Inc
  4. 50114-6134
  5. Label Information: Abropernol

FDA Label for Abropernol

View Indications, Usage & Precautions

Table of Contents

    1. KEEP OUT OF REACH OF CHILDREN
    2. INDICATIONS AND USAGE
    3. WARNINGS
    4. DOSAGE AND ADMINISTRATION
    5. ACTIVE INGREDIENT
    6. INACTIVE INGREDIENT
    7. PURPOSE

Abropernol Product Label

The following document was submitted to the FDA by the labeler of this product Heel Inc. The document includes published materials associated whith this product with the essential scientific information about this product as well as other prescribing information. Product labels may durg indications and usage, generic names, contraindications, active ingredients, strength dosage, routes of administration, appearance, warnings, inactive ingredients, etc.

Keep Out Of Reach Of Children



Keep this and all medications out of the reach of children.

Indications And Usage



For the temporary relief of:
  • Dermatitus
  • Minor skin irritations
  • Eczema, hyperhidrosis
  • Hyperkeratosis



Warnings



If symptoms persist or worsen, a physician should be consulted. As with any drug, if you are pregnant or nursing a baby, seek the advise of a health care professional before using this product.

Dosage And Administration



Adults and children above 6 years: 1 tablet sublingually or dissolved completely in mouth 3 times daily or as directed by a physician.Infants and children to 6 years: 1/2 the adult dosage.

Active Ingredient



Each 300mg tablet contains as active ingredients: Abrotanum 4X, Pulsatilla 4X, Calcarea fluorica 12X 60 mg each; Hamamelis virginiana 4X, Agaricus muscarius 5X, Nitricum acidum 6X, Petroleum 6X 30 mg each.

Inactive Ingredient



Inactive ingredients: Lactose, Magnesium Stearate

Purpose



Dermatitus, Minor skin irritations, Eczema, hyperhidrosis, Hyperkeratosis

* Please review the disclaimer below.